论文部分内容阅读
医药企业为了不断的发展和壮大,应对日益激烈的国内、国际市场竞争,基于市场资源、品种资源、品牌资源等因素,进行了一个又一个的并购行为。为了检验我国医药企业并购所取得的的效果,选取53家在2000年完成并购的医药上市公司为样本,对其并购前后的绩效进行实证研究。结果表明:样本公司在短期内绩效得到提升,但是从长期来看,绩效出现了下滑。
In order to keep developing and expanding, the pharmaceutical enterprises responded to the increasingly fierce domestic and international market competition and carried out mergers and acquisitions one after another based on such factors as market resources, variety resources and brand resources. In order to test the effect of mergers and acquisitions of Chinese pharmaceutical enterprises, 53 listed pharmaceutical companies that completed mergers and acquisitions in 2000 were selected as samples to conduct an empirical study on their performance before and after mergers and acquisitions. The results show that sample companies have improved their performance in the short term, but in the long run, performance has declined.